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Introduction
Hydroxysteroid dehydrogenases (HSDs) The availability of the X-ray crystal structure of AKR1C1 as a complex with 20α-OHP Couture et al., 2003 enabled us to perform a virtual high-throughput screening with the National Cancer Institute (NCI) "Diversity Set" bank of compounds, and to biochemically evaluate the most promising inhibitors that were selected by the eHiTS software. Three inhibitors were obtained that represent promising starting points for further optimization. M a n u s c r i p t
Materials and methods

Virtual high-throughput screening
The Diversity Set that consists of 1,990 compounds in DMSO solution in 96-well microtiter plates was obtained from the NCI. Compounds detected as hits after an initial screening were acquired from the NCI as solid samples. The three-dimensional (3D) structures of compounds from the NCI Diversity Set were obtained from the NCI web page (http://dtp.nci.nih.gov/dw/testmasters/chem3d.html). No special preparation of the 3D structures was carried out since eHiTS automatically evaluates all of the possible protonation states for ligands and enzymes. Virtual screening was carried out on a workstation with two Xeon 2.4 GHz processors, 2 GB RAM, 120 GB hard drive and Nvidia Geforce 6600 GT graphic card running Red Hat Linux 9.0. eHiTS 6.0 from SimBioSys Inc. was used for active site detection and docking (Zsoldos et al., 2006a) . Open Babel was used for manipulating the various chemical formats of ligands. PyMol from DeLano Scientific was used for visual inspection of results and graphical presentations. CACTVS tools were used for 2D structure visualization.
Virtual screening on AKR1C1 was done on its crystal structure in complex with 20α-OHP (PDB entry 1MRQ). This structure was solved at 1.59 Å resolution (Couture et al., 2003) and was used without any modifications. The enzyme was initially prepared with eHiTS. Active-site detection was carried out using the "-complex" parameter with high accuracy. The program automatically detected the ligand in the complex and selected the part of enzyme within a 7 Å margin around the ligand to be the active site. The NCI Diversity Set was then docked to the active site using the fastest mode of docking (accuracy set to 1). Two hundred of the best scoring compounds from the first run were then re-docked with a higher accuracy setting (set to 6) and scored with eHiTS_Score, which is included in the eHiTS software package (Zsoldos et al., 2006b ).
Expression and purification of recombinant AKR1C1
pGEX-AKR1C1 (constructed from a pcDNA3-AKR1C1 vector provided by Dr. Trevor M.
Penning) (Brožič et al., 2006) was transferred into the BL21 Escherichia coli strain. The cells were then grown in Luria-Bertani medium containing 100 µg/ml ampicillin, at 37 °C in a rotary shaker, until an OD 600 of 1.0 had been reached. Expression of AKR1C1 was induced by IPTG at a final concentration of 1 mM, and the incubation was continued for 16 h at 24 °C (Krazeisen et al., 2001; Couture et al., 2002) . The preparation of cell extracts, the purification M a n u s c r i p t of glutathione-S-transferase (GST)-fusion proteins by affinity binding to glutathioneSepharose, and the cleavage with thrombin, were all performed as described in the GST Gene Fusion System Handbook (Amersham Biosciences). Protein concentrations were determined using the Bradford method, with bovine serum albumin as standard, and the homogeneity of the protein was checked by SDS PAGE followed by Coomassie Blue staining.
Inhibition assay
Human recombinant AKR1C1 catalyzes the oxidation of 1-acenaphthenol in the presence of the coenzyme NAD + . The reaction was followed spectrophotometrically by measuring the increase in NADH absorbance ( 340 = 6220 M -1 .cm -1 ) in the absence and presence of each of the compounds. The screening was carried out in a 0.3-ml volume that included 100 mM phosphate buffer (pH 6.5), 0.005% Triton X-114 and 5% DMSO as a co-solvent. A substrate concentration close to the determined Km value was used, with 2.3 mM coenzyme and 1.0 µM enzyme. The concentrations of the compounds ranged from 1 µM to 100 µM. The measurements were performed on a Tecan Safire²™ microplate reader, with initial velocities calculated, and the IC 50 values were determined graphically from plots of log 10 (inhibitor concentration) versus % inhibition, using GraphPad Prism Version 4.00 (GraphPad Software,
Inc.).
M a n u s c r i p t
Results and Discussion
Virtual screening is an automated computational technique that can be used for screening large databases of compounds and that is gaining importance in modern drug discovery. Its aim is to reduce large numbers of compounds to smaller subsets that are more likely to contain biologically active compounds. Virtual screening applied to the discovery of new enzyme inhibitors involves docking, the computational fitting of structures of compounds to the active site of an enzyme, and scoring and ranking each compound. The highest ranked compounds are then tested for their activities in a biological or biochemical assay (Guido et al., 2008 ).
For our docking experiments, we used eHiTS 6.0 software. eHiTS is a program for flexible ligand docking that applies systematic algorithms to sample all of the possible degrees of freedom of a molecule. Ligands were first divided into rigid fragments and flexible chains, and each fragment was then docked independently into the active site. The program applied the fast graph matching algorithm to reconstruct the original molecule from the docking of its small rigid fragments. They were then reconnected with flexible chains, and local energy optimization within the receptor was then performed, followed by scoring. The scoring was based on the eHiTS_Scores of a statistically derived empirical scoring function (Zsoldos et al., 2006a; Zsoldos et al., 2006b ).
The NCI "Diversity Set" is a library of 1,990 compounds that were selected from the original NCI-3D structural database for their unique scaffolds. The compounds are freely available as solutions in DMSO in microtiter plates. Each compound from the NCI Diversity Set was docked to AKR1C1 using eHiTS, and this resulted in a list of potential inhibitors ranked according to the eHiTS scoring function. Only the top 50 compounds (Table 1) were then evaluated in in-vitro biochemical assays. Among the compounds tested, three structurally diverse hits ( Table 2 ) were obtained that inhibited the enzyme in the low micromolar range of IC 50 values. As these inhibitors have new scaffolds they can be used as promising starting points for further synthetic structural modifications and optimization as well as for additional computer-assisted methods like 2D and 3D similarity searches. (Fig. 2) . The most important predicted interaction is a hydrogen bond between one of the inhibitor carboxylates and Tyr55 of the catalytic tetrade. Also, the M a n u s c r i p t inhibitor NSC92412 forms mainly hydrophobic interactions: the indene ring is docked into the hydrophobic pocket that is formed by Ile129, Pro226, Val228, Leu306, Leu308 and Ile310. It is interesting to note that eHiTS did not predict the binding of the inhibitor hydroxyl group to the oxyanion hole, which is located at the bottom of the steroid-binding pocket and is formed by the catalytic tetrade residues Tyr55, His117, Asp50 and Lys84, and the cofactor nicotinamide ring. Instead, eHiTS predicted that the pyridine ring of inhibitor NSC92412 has π stacking interactions with the nicotinamide ring of the cofactor NADP + , while the free hydroxyl group is pointing away from the catalytic tetrade.
While we were preparing this manuscript, Dhagat and co-workers published another virtual screening for the identification of new AKR1C1 inhibitors (Dhagat et al., 2007) . They (including salicylic and acetyl salicylic acid) were described as potent inhibitors of AKR1C1.
However, the hit inhibitors obtained in the Dhagat study differ from the active compounds found with our virtual screening of the NCI Diversity Set. This is not surprising since different docking and scoring programs were used in the virtual screens.
To conclude, we have carried out virtual screening of compounds from the NCI database in our search for novel inhibitors of AKR1C1, an essential enzyme that is involved in progesterone metabolism and an emerging target for anticancer drug discovery. Fifty of the best ranked compounds were evaluated in in-vitro assays, and three hits were obtained that inhibit the enzyme in a low micromolar concentration range. These inhibitors represent promising starting points for further optimization.
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